Languages: en  fr 

Eurofins Pharma Services - Biomarker Services

Non clinical and clinical Biomarkers with highest standards of quality and logistics

ES_Breda_LC-MS-MS.jpgEurofins Pharma Services has a dedicated expert network of biomarker scientists. This activity originates from bioanalytical work and explains the outstanding high standards of quality we apply in this field. Eurofins Pharma Services developed vigorously the biomarker activity from a bioanalytical service in a central lab environment to an integrated, holistic approach of Biomarker discovery, development and measurement. We are in an interactive partnership with our clients to define their needs for a biomarker and working out a plan of the requirements. This can include the following actions depending on the level of validation required for the study.

 

  • Fit-for-Purpose validation in compliance with GLP regulatory guidelines
  • NCCLS/CLIA validated analysis
  • Sponsor specific requirements

 

This Biomarker service is completely integrated in our logistical network providing the appropriate sampling, storage and shipment conditions. Our logistic expertise reduces the organizational efforts for the clients such as sample handling to a minimum. Eurofins Pharma Services does not only deliver the high quality data but put these also into the preclinical and clinical context of your project. .

Scientific leadership for biomarker

 

We have set up a new collaborative Eurofins Medinet laboratory in Denver, USA with Prof. U. Christians of the University of Colorado who is a specialist in the discovery and development of new biomarkers and with Dr. P. Braquet of Eurofins Medinet in Paris, France, who is a leading authority in the biomarker world. These collaborations provide us a very strong scientific fundament supporting our role in the analysis of biomarkers in clinical and preclinical studies.

 

For further information please contact us: pharma@eurofins.com